Abstract:Purpose: N 6 -methyladenosine (m 6 A) mRNA methylation is affected by dietary factors and associated with lipid metabolism; however, whether the regulatory role of resveratrol in lipid metabolism is involved in m 6 A mRNA methylation remains unknown. Here, the objective of this study was to investigate the effect of resveratrol on hepatic lipid metabolism and m 6 A RNA methylation in the liver of mice. Methods: A total of 24 male mice were randomly allocated to LFD (low-fat diet), LFDR (low-fat diet + resveratrol), HFD (high-fat diet), and HFDR (high-fat diet + resveratrol) groups for 12 weeks ( n = 6/group). Final body weight of mice was measured before sacrificing. Perirhemtric fat, abdominal and epididymal fat, liver tissues, and serum were collected at sacrifice and analyzed. Briefly, mice phenotype, lipid metabolic index, and m 6 A modification in the liver were assessed. Results: Compared to the HFD group, dietary resveratrol supplementation reduced the body weight and relative abdominal, epididymal, and perirhemtric fat weight in high-fat-exposed mice; however, resveratrol significantly increased average daily feed intake in mice given HFD. The amounts of serum low-density lipoprotein cholesterol (LDL), liver total cholesterol (TC), and triacylglycerol (TAG) were significantly decreased by resveratrol supplementation. In addition, resveratrol significantly enhanced the levels of peroxisome proliferator-activated receptor alpha ( PPARα ), peroxisome proliferator-activated receptor beta/delta ( PPARβ/δ ), cytochrome P450, family 4, subfamily a, polypeptide 10/14 ( CYP4A10 / 14 ), acyl-CoA oxidase 1 ( ACOX1 ), and fatty acid-binding protein 4 ( FABP4 ) mRNA and inhibited acyl-CoA carboxylase ( ACC ) mRNA levels in the liver. Furthermore, the resveratrol in HFD increased the transcript levels of methyltransferase like 3 ( METTL3 ), alkB homolog 5 ( ALKBH5 ), fat mass and obesity associated protein ( FTO ), and YTH domain family 2 ( YTHDF2 ), whereas it decreased the level of YTH domain family 3 ( YTHDF3 ) and m 6 A abundance in mice liver. Conclusion: The beneficial effect of resveratrol on lipid metabolism disorder under HFD may be due to decrease of m 6 A RNA methylation and increase of PPARα mRNA, providing mechanistic insights into the function of resveratrol in alleviating the disturbance of lipid metabolism in mice.

Resveratrol Prevents Suppression of Regulatory T-cell Production, Oxidative Stress, and Inflammation of Mice Prone or Resistant to High-Fat Diet–induced Obesity

Regulatory Effects of Resveratrol on Glucose Metabolism and T-Lymphocyte Subsets in the Development of High-Fat Diet-Induced Obesity in C57bl/6 Mice

Resveratrol Preserves Mitochondrial Function, Stimulates Mitochondrial Biogenesis, and Attenuates Oxidative Stress in Regulatory T Cells of Mice Fed a High-Fat Diet.

Increased Oxidative Stress and the Apoptosis of Regulatory T Cells in Obese Mice but Not Resistant Mice in Response to a High-Fat Diet.

Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice.

The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression

Effects of Resveratrol on Redox State of Adipose Tissue and Lipid of Mice Fed with High-fat Diet

Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats

Resveratrol Protects Against Renal Damage Via Attenuation of Inflammation and Oxidative Stress in High-Fat-Diet-Induced Obese Mice

Protective Effects of Dietary Resveratrol against Chronic Low-Grade Inflammation Mediated through the Gut Microbiota in High-Fat Diet Mice

Resveratrol-induced Gut Microbiota Reduces Obesity in High-Fat Diet-Fed Mice.

Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota

Effects of Resveratrol on Gut Microbiota and Fat Storage in A Mouse Model with High-Fat-Induced Obesity

Resveratrol Ameliorates Metabolic Disorders and Insulin Resistance in High-Fat Diet-Fed Mice.

Resveratrol Attenuates High-Fat Diet Induced Hepatic Lipid Homeostasis Disorder and Decreases m6A RNA Methylation

Sinapic Acid and Resveratrol Alleviate Oxidative Stress with Modulation of Gut Microbiota in High-Fat Diet-Fed Rats.

Resveratrol protects against a high-fat diet-induced neuroinflammation by suppressing mitochondrial fission via targeting SIRT1/PGC-1α

Resistant dextrin reduces obesity and attenuates adipose tissue inflammation in high-fat diet-fed mice

Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation

Protective Effect of Resveratrol Against Hepatic Damage Induced by Heat Stress in a Rat Model is Associated with the Regulation of Oxidative Stress and Inflammation.

Dietary resveratrol attenuated colitis and modulated gut microbiota in dextran sulfate sodium-treated mice.